Impact of imatinib on the fertility of male patients with chronic myelogenous leukaemia in the chronic phase

X Chang, L Zhou, X Chen, B Xu, Y Cheng, S Sun… - Targeted …, 2017 - Springer
Background Imatinib is a first-line tyrosine kinase inhibitor for treating chronic myelogenous
leukaemia (CML) and has greatly improved the prognosis of this disease. An increasing …
被引用次数：39 相关文章

Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase.

X Chang, L Zhou, X Chen, B Xu, Y Cheng, S Sun… - Targeted …, 2017 - europepmc.org
Background Imatinib is a first-line tyrosine kinase inhibitor for treating chronic myelogenous
leukaemia (CML) and has greatly improved the prognosis of this disease. An increasing …

Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase

X Chang, L Zhou, X Chen, B Xu, Y Cheng… - Targeted …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Imatinib is a first-line tyrosine kinase inhibitor for treating chronic myelogenous
leukaemia (CML) and has greatly improved the prognosis of this disease. An increasing …

Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase

X Chang, L Zhou, X Chen, B Xu, Y Cheng, S Sun… - Targeted Oncology, 2017 - infona.pl
Background Imatinib is a first-line tyrosine kinase inhibitor for treating chronic myelogenous
leukaemia (CML) and has greatly improved the prognosis of this disease. An increasing …

Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase

X Chang, L Zhou, X Chen, B Xu, Y Cheng… - Targeted …, 2017 - search.proquest.com
Background Imatinib is a first-line tyrosine kinase inhibitor for treating chronic myelogenous
leukaemia (CML) and has greatly improved the prognosis of this disease. An increasing …